Filing status
- Accounts due
- 31 July 2027
- Last accounts
- 31 October 2025
- Conf. stmt due
- 25 February 2027
- Last conf. stmt
- 11 February 2026
Rem Pharma Ltd
- Incorporated
- 6 October 2020 (6 years)
- Industry
- General medical practice activities (86210)
- Owned by
- Accounts type
- Unaudited abridged
- Region
- South East
- Address
- PharmaethicalWorkshop 4Maidstone Innovation CentreGidds Pond WayWeaveringMaidstoneME14 5FY
Officers
Not loaded yet. See them on Companies House
Ownership 2 active
People and entities with significant control, from the Companies House PSC register
Private Limited Company
Reg. no. 12183972
Ltd
Reg. no. 11472869
Former controllers (6)
10 February 2025
Ceased Lad & Lad Limited — Owns 25–50% of shares
10 February 2025
Ceased Medichest Limited — Owns 25–50% of shares
10 February 2025
Ceased Pharmacare Plus UK Ltd — Owns 25–50% of shares
17 December 2023
Ceased Mukeshbhai Chhaganlal Lad — Owns 25–50% of shares
1 January 2022
Ceased Ebrahim Farook Aziz — Owns 25–50% of shares
1 January 2022
Ceased Riaz Ahamed Abdul Sattar Omar — Owns 25–50% of shares
Financials
Balance sheet as at 31 October 2025 · unaudited abridged accounts
- Net Assets
- (£75,393)
- Cash
- £0
- Employees
- 2
- Debt Ratio
- 682%
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Fixed Assets | £5,000 | £10,000 | £15,000 | £20,000 | |
| Current Assets | £7,960 | £444 | £148 | £39,016 | |
| Debtors | £7,960 | £0 | £77 | £9,065 | |
| Cash | £0 | £444 | £71 | £6,286 | £1 |
| Creditors (< 1 year) | £36,418 | £66,351 | |||
| Net Current Assets | (£80,393) | (£38,877) | (£36,270) | (£27,335) | £1 |
| Net Assets | (£75,393) | (£28,877) | (£21,270) | (£7,335) | £1 |
| Shareholder Funds | £1 |
Filings
Filing history not loaded yet. See it on Companies House
Other companies in this industry
Camelford
London
London
Kingston Upon Thames
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →